Tyr219
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus®
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Tyr219  -  ADRB2 (human)

Site Information
LVIMVFVySRVFQEA   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 4047200

In vivo Characterization
Methods used to characterize site in vivo:
mutation of modification site ( 2 ) , phospho-antibody ( 2 ) , western blotting ( 2 )
Relevant cell line - cell type - tissue:
293 (epithelial) ( 2 )

Downstream Regulation
Effects of modification on ADRB2:
activity, induced ( 2 )

References 

1

Choi M, et al. (2018) G protein-coupled receptor kinases (GRKs) orchestrate biased agonism at the β-adrenergic receptor. Sci Signal 11
30131371   Curated Info

2

Wisler JW, et al. (2007) A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling. Proc Natl Acad Sci U S A 104, 16657-62
17925438   Curated Info